文章摘要

声触诊组织量化成像技术联合血清Ca153对乳腺结节良恶性的诊断价值

作者: 1,2祁汉中, 1倪雪君, 1陈希
1 南通大学附属医院超声科,南通大学医学院,江苏 南通 226001
2 建湖县人民医院超声科,江苏 盐城 224700
通讯: 倪雪君 Email: lily0138@163.com
DOI: 10.3978/j.issn.2095-6959.2022.11.009

摘要

目的:探究声触诊组织量化成像(virtual touch tissue imaging quantification,VTIQ)技术联合血清抗癌原153(carcinoma marker 153,Ca153)对乳腺结节良恶性的评价效果。方法:回顾性选取2020年1月至2021年12月在建湖县人民医院就诊的112例乳腺实质性结节患者为研究对象,以术后病理结果作为金标准,将112例乳腺结节患者分为恶性组与良性组,比较VTIQ技术测量结节剪切波速度值(shear wave velocity,SWV)、血清Ca153与两者联合诊断乳腺结节良恶性的敏感度、预测值、准确率、漏诊率、误诊率,并比较三者诊断乳腺结节良恶性与病理结果的一致性。结果:112例乳腺结节经病理检查显示:良性乳腺结节79例,恶性乳腺结节33例。恶性乳腺结节组SWV值与Ca153均显著高于良性乳腺结节组,差异有统计学意义(P<0.05)。受试者工作特征(receiver operating characteristic,ROC)曲线显示:SWV值与Ca153水平诊断乳腺结节良恶性最佳阈值为4.385 m/s与31.465 U/mL,VTIQ技术SWV值诊断乳腺结节恶性的敏感度为78.79%(26/33),诊断乳腺结节良性的敏感度为96.20%(76/79);血清Ca153诊断乳腺结节恶性的敏感度为72.73%(24/33),诊断乳腺结节良性的敏感度为98.73%(78/79);联合诊断乳腺结节恶性的敏感度为93.94%(31/33),诊断乳腺结节良性的敏感度为100.00%(79/79)。VTIQ技术SWV值诊断乳腺结节良恶性与病理检查相比,Kappa值为0.837,两者一致性较好;血清Ca153诊断乳腺结节良恶性与病理检查相比,Kappa值为0.769,两者一致性较好;联合诊断乳腺结节良恶性与病理检查相比,Kappa值为0.956,两者一致性较好,且联合诊断Kappa值显著高于VTIQ技术SWV值与血清Ca153单独诊断的Kappa值(P0.05),但两者联合诊断乳腺结节良恶性的准确率高于VTIQ技术与血清Ca153(P<0.05)。结论:VTIQ技术联合血清Ca153诊断鉴别乳腺结节良恶性具有较高价值,可有效提高诊断准确率。
关键词: 乳腺结节;良恶性;声触诊组织量化成像技术;血清Ca153 ;联合诊断

Diagnostic value of virtual touch tissue quantitative imaging quantification technique combined with serum Ca153 in benign and malignant breast nodules

Authors: 1,2QI Hanzhong, 1NI Xuejun, 1CHEN Xi
1 Department of Ultrasound, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong Jiangsu 226001, China
2 Department of Ultrasound, Jianhu County People’s Hospital, Yancheng Jiangsu 224700, China

CorrespondingAuthor: NI Xuejun Email: lily0138@163.com

DOI: 10.3978/j.issn.2095-6959.2022.11.009

Abstract

Objective: To explore the effect of virtual touch tissue imaging quantification (VTIQ) combined with serum carcinoma marker 153 (Ca153) on the evaluation of benign and malignant breast nodules. Methods: A total of 112 patients with breast parenchymal nodules who were treated in Jianhu County People’s Hospital from January 2020 to December 2021 were retrospectively selected as research subjects. Using postoperative pathological results as the gold standard, 112 patients with breast nodules were divided into a malignant and a benign group. The sensitivity, predictive value, accuracy rate, missed diagnosis rate, misdiagnosis rate of nodule shear wave velocity (SWV), serum Ca153, and their combination in diagnosing benign and malignant breast nodules. The consistency of the diagnosis of benign and malignant breast nodules and the pathological results were compared among the 3 methods. Results: Pathological examination of 112 breast nodules showed that there were 79 benign breast nodules and 33 malignant breast nodules. The SWV value and Ca153 in the malignant breast nodule group were significantly higher than those in the benign breast nodule group, and the difference was statistically significant (P<0.05). The ROC curve shows that the optimal thresholds of SWV value and Ca153 level for the diagnosis of benign and malignant breast nodules were 4.385 m/s and 31.465 U/mL. The SWV value of VTIQ technique had a sensitivity of 78.79% (26/33) in diagnosing malignant breast nodules; the sensitivity of diagnosing benign breast nodules was 96.20% (76/79); the sensitivity of serum Ca153 in diagnosing breast nodule malignancy was 72.73% (24/33); the sensitivity of diagnosing benign breast nodules was 98.73% (78/79); the sensitivity of combined diagnosis of breast nodule malignancy was 93.94% (31/33); the sensitivity for diagnosing benign breast nodules was 100.00% (79/79). Compared with the pathological examination, the SWV value of VTIQ technology in the diagnosis of benign and malignant breast nodules had a Kappa value of 0.837, and the two were in good agreement. Compared with the pathological examination, the Kappa value of serum Ca153 in the diagnosis of benign and malignant breast nodules was 0.769, and the two were in good agreement. Compared with the pathological examination, the Kappa value of the joint diagnosis of benign and malignant breast nodules was 0.956, and the consistency between the two was good. The Kappa value of the combined diagnosis was significantly higher than the SWV value of VTIQ technology and serum Ca153 alone diagnosis Kappa value (P<0.05). There was no significant difference in missed detection rate and misdiagnosis rate among VTIQ technology, serum Ca153, and their combined diagnosis (P>0.05). However, the accuracy of the 2 combined diagnosis of benign and malignant breast nodules was higher than that of VTIQ technology and serum Ca153 (P<0.05). Conclusion: Virtual touch tissue imaging quantification technology combined with serum Ca153 has high value in the diagnosis and differentiation of benign and malignant breast nodules and can effectively improve the diagnostic accuracy.

Keywords: breast nodules; benign and malignant; virtual touch tissue imaging quantification; serum Ca153; combined diagnosis

文章选项